Abstract:Aim Fistula-in-ano (FIA) is associated with high treatment costs and has a deleterious impact on quality of life. A wide range of healing, incontinence and recurrence rates have been reported. This study aimed to identify operative, patient and disease factors that influence these outcomes after surgery for FIA. Method An observational cohort study of consecutive patients who were managed for FIA at a tertiary colorectal practice (1999-2019) was performed. Outcome measures included healing, impaired continence… Show more
“…43 Unfortunately, compared to patients undergoing repair of cryptoglandular anal fistulas, patients with CD-associated perianal disease have lower rates of initial and definitive closure as well as a higher risk of requiring multiple repair procedures. 44 Still, multiple studies, including at least one randomized trial, have demonstrated that the addition of surgical closure to baseline medical therapy improves long-term healing rates and decreases the risk of future procedural intervention. 45 For all repair procedures, the general goal remains the same: improvement if not resolution of fistula symptoms without altering or impairing fecal continence.…”
Section: Pathogenesis Classification and Initial Evaluationmentioning
Perianal fistulizing Crohn's disease is one of the most disabling phenotypes of Crohn's disease, due to the severe impairment in quality of life including social and personal wellbeing. A multimodal approach with patient-tailored care is the key to optimal management of this condition. Medical therapy is needed to optimize the luminal disease, and surgical intervention is required to control any associated perianal sepsis and attempt palliative or definitive fistula repair. While several medical and surgical options are available, the majority of patients continue to have symptomatic disease. Fortunately, this continues to drive novel innovations which are revolutionizing the treatment and outcomes of perianal fistulizing Crohn's disease. However, there continues to be a need for randomized trials and consistent metrics utilized for classification and treatment outcomes in order to accurately describe optimal treatment outcomes.
“…43 Unfortunately, compared to patients undergoing repair of cryptoglandular anal fistulas, patients with CD-associated perianal disease have lower rates of initial and definitive closure as well as a higher risk of requiring multiple repair procedures. 44 Still, multiple studies, including at least one randomized trial, have demonstrated that the addition of surgical closure to baseline medical therapy improves long-term healing rates and decreases the risk of future procedural intervention. 45 For all repair procedures, the general goal remains the same: improvement if not resolution of fistula symptoms without altering or impairing fecal continence.…”
Section: Pathogenesis Classification and Initial Evaluationmentioning
Perianal fistulizing Crohn's disease is one of the most disabling phenotypes of Crohn's disease, due to the severe impairment in quality of life including social and personal wellbeing. A multimodal approach with patient-tailored care is the key to optimal management of this condition. Medical therapy is needed to optimize the luminal disease, and surgical intervention is required to control any associated perianal sepsis and attempt palliative or definitive fistula repair. While several medical and surgical options are available, the majority of patients continue to have symptomatic disease. Fortunately, this continues to drive novel innovations which are revolutionizing the treatment and outcomes of perianal fistulizing Crohn's disease. However, there continues to be a need for randomized trials and consistent metrics utilized for classification and treatment outcomes in order to accurately describe optimal treatment outcomes.
“…This has led to the development of new strategies to improve current techniques. 2 Historically, seton placement was the main method of surgical management for most perianal fistulas. Setons allow the drainage of associated abscesses while promoting the resolution of the tract through a local inflammatory process.…”
Background: Cryptoglandular perianal fistulas are a frequent problem, and the traditional surgical procedure carries a risk of incontinence and recurrence. The ultimate goal of fistula management is to resolve and prevent sepsis, eradicate the fistula, prevent recurrence, and ensure continence. Laser Ablation of Fistula Tract (LAFT) offers a viable alternative sphincter-saving modality.
Patient and methods:In this study, we performed a randomized controlled trial to evaluate the safety and efficacy of laser ablation as a treatment for transsphincteric fistulas. This study was conducted at Ain Shams University hospitals from June 2019 to June 2022 and included eighty patients with cryptoglandular transsphincteric fistulas who had undergone previous drainage and seton, they were divided into two groups. The first group (Group A) underwent fistulectomy with subsequent sphincteroplasty while the second group (Group B) underwent laser ablation of the fistula tract. Follow-up was scheduled in the outpatient clinic at 1 and 2 weeks and 1, 3, and 6 months postoperatively. The Cleveland Clinic Florida Fecal Incontinence CCF-FI score and the visual analog scale (VAS) score were recorded at each visit.
Results:The results of the study showed that the laser ablation of the fistula track technique is a safe and effective sphincter-saving modality for transsphincteric fistula management with acceptable healing rates. The technique also carries the advantages of a short learning curve, reduced hospital stay, and minimal risk of incontinence.
Conclusion:Our study found that laser ablation is a safe and effective treatment option for transsphincteric fistulas. Preliminary seton insertion may have a positive impact on postoperative outcome. However, there is a need for further research to evaluate the long-term outcomes..
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.